BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 18678378)

  • 1. Influence of statins treatment on survival in patients with amyotrophic lateral sclerosis.
    Drory VE; Bronipolsky T; Artamonov I; Nefussy B
    J Neurol Sci; 2008 Oct; 273(1-2):81-3. PubMed ID: 18678378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival rate of patients with amyotrophic lateral sclerosis in Wakayama Prefecture, Japan, 1966 to 2005.
    Kihira T; Yoshida S; Okamoto K; Kazimoto Y; Ookawa M; Hama K; Miwa H; Kondo T
    J Neurol Sci; 2008 May; 268(1-2):95-101. PubMed ID: 18164728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Survival in amyotrophic lateral sclerosis].
    Alcaz S; Jarebinski M; Pekmezović T; Marinković Z; Apostolski S
    Srp Arh Celok Lek; 1997; 125(1-2):19-23. PubMed ID: 17974351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of a data mining signal for amyotrophic lateral sclerosis and statins detected in FDA's spontaneous adverse event reporting system.
    Colman E; Szarfman A; Wyeth J; Mosholder A; Jillapalli D; Levine J; Avigan M
    Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1068-76. PubMed ID: 18821724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation between primary lateral sclerosis and amyotrophic lateral sclerosis: examination of symptoms and signs at disease onset and during follow-up.
    Tartaglia MC; Rowe A; Findlater K; Orange JB; Grace G; Strong MJ
    Arch Neurol; 2007 Feb; 64(2):232-6. PubMed ID: 17296839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory systems abnormalities and clinical milestones for patients with amyotrophic lateral sclerosis with emphasis upon survival.
    Vender RL; Mauger D; Walsh S; Alam S; Simmons Z
    Amyotroph Lateral Scler; 2007 Feb; 8(1):36-41. PubMed ID: 17364434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyotrophic lateral sclerosis: prognostic indicators of survival.
    Mandrioli J; Faglioni P; Nichelli P; Sola P
    Amyotroph Lateral Scler; 2006 Dec; 7(4):211-20. PubMed ID: 17127559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins and amyotrophic lateral sclerosis--the level of evidence for an association.
    Sørensen HT; Lash TL
    J Intern Med; 2009 Dec; 266(6):520-6. PubMed ID: 19930099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and survival pattern of 1,153 patients with amyotrophic lateral sclerosis: experience over 30 years from India.
    Nalini A; Thennarasu K; Gourie-Devi M; Shenoy S; Kulshreshtha D
    J Neurol Sci; 2008 Sep; 272(1-2):60-70. PubMed ID: 18550082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An observational study of cognitive impairment in amyotrophic lateral sclerosis.
    Rippon GA; Scarmeas N; Gordon PH; Murphy PL; Albert SM; Mitsumoto H; Marder K; Rowland LP; Stern Y
    Arch Neurol; 2006 Mar; 63(3):345-52. PubMed ID: 16533961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Survival prediction and related risk factors of amyotrophic lateral sclerosis:analysis of 65 cases].
    Qiao L; Zhang J; Fan DS
    Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(11):742-5. PubMed ID: 18683681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender-based effect of statins on functional decline in amyotrophic lateral sclerosis.
    Nefussy B; Hirsch J; Cudkowicz ME; Drory VE
    J Neurol Sci; 2011 Jan; 300(1-2):23-7. PubMed ID: 21056430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing incidence of ALS in Canterbury, New Zealand: a 22-year study.
    Murphy M; Quinn S; Young J; Parkin P; Taylor B
    Neurology; 2008 Dec; 71(23):1889-95. PubMed ID: 19047561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of young-adult amyotrophic lateral sclerosis.
    Sabatelli M; Madia F; Conte A; Luigetti M; Zollino M; Mancuso I; Lo Monaco M; Lippi G; Tonali P
    Neurology; 2008 Sep; 71(12):876-81. PubMed ID: 18596241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival of 793 patients with amyotrophic lateral sclerosis diagnosed over a 28-year period.
    Testa D; Lovati R; Ferrarini M; Salmoiraghi F; Filippini G
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Dec; 5(4):208-12. PubMed ID: 15799548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis.
    Turner MR; Bakker M; Sham P; Shaw CE; Leigh PN; Al-Chalabi A
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Mar; 3(1):15-21. PubMed ID: 12061944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An outcome study of riluzole in amyotrophic lateral sclerosis--a population-based study in Ireland, 1996-2000.
    Traynor BJ; Alexander M; Corr B; Frost E; Hardiman O
    J Neurol; 2003 Apr; 250(4):473-9. PubMed ID: 12700914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors predicting survival following noninvasive ventilation in amyotrophic lateral sclerosis.
    Peysson S; Vandenberghe N; Philit F; Vial C; Petitjean T; Bouhour F; Bayle JY; Broussolle E
    Eur Neurol; 2008; 59(3-4):164-71. PubMed ID: 18230874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ALSFRSr predicts survival time in an ALS clinic population.
    Kaufmann P; Levy G; Thompson JL; Delbene ML; Battista V; Gordon PH; Rowland LP; Levin B; Mitsumoto H
    Neurology; 2005 Jan; 64(1):38-43. PubMed ID: 15642901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do bulbar-onset amyotrophic lateral sclerosis patients have an earlier respiratory involvement than spinal-onset amyotrophic lateral sclerosis patients?
    Pinto S; Pinto A; De Carvalho M
    Eura Medicophys; 2007 Dec; 43(4):505-9. PubMed ID: 18084174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.